Misonix Inc. (MSON) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Misonix Inc. (MSON)

MSON 26.54

0.0%

Nov 22 3:00 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext

From: Savant	10/26/2021 5:20:58 PM
	of 947

Bioventus (NASDAQ: BVS) stockholders approved the company's previously announced acquisition of Misonix (NASDAQ: MSON).“The combination with Misonix creates significant value and provides a deeper global portfolio of pain treatments, restorative therapies and surgical solutions for patients," said Bioventus CEO Ken Reali.Under the agreement, Misonix stockholders will receive either (i) 1.6839 shares of Bioventus or (ii) $28.00 in cash, for each share of Misonix common stock they hold.The acquisition is expected to close around October 29, 2021.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext